文献速递儿童心血管与肾脏儿童内分泌与遗传代谢

儿童肺动脉瓣狭窄患者中努南谱系障碍的患病率

The Prevalence of Noonan Spectrum Disorders in Pediatric Patients with Pulmonary Valve Stenosis.
PubMed 文献 · J Pediatr · 2021-03-29

该回顾性病历回顾研究了2009至2019年科罗拉多儿童医院心脏科686例肺动脉瓣狭窄(PVS)患儿,发现努南谱系障碍占9%,且与房间隔缺损、肥厚型心肌病、瓣上型肺动脉狭窄及多种心外特征相关,提示PVS患儿应警惕努南谱系障碍并考虑遗传学评估。

要点

  • PVS患儿中努南谱系障碍患病率为9%,应引起临床警惕。
  • PVS合并房间隔缺损、肥厚型心肌病或瓣上型肺动脉狭窄时更需考虑努南谱系障碍。
  • PVS伴喂养问题、发育迟缓、身材矮小、眼部异常等特征应启动遗传学评估。

核心结论

  • PVS患儿中努南谱系障碍的患病率为9%,临床医生接诊PVS患儿时应考虑该诊断。
  • PVS合并1项及以上努南谱系障碍相关特征时应进行遗传学评估及RAS通路缺陷的基因检测。
  • 瓣上型肺动脉狭窄患者也应将努南谱系障碍纳入鉴别诊断。

研究设计与样本

  • 回顾性病历回顾,纳入2009至2019年科罗拉多儿童医院心脏科门诊诊断为PVS的686例儿科患者。
  • 记录综合征诊断、基因型、心脏特征及与努南谱系障碍相关的心外特征,使用R进行统计分析。

主要发现

  • 686例PVS患儿中16%有综合征诊断,努南谱系障碍占总诊断的9%。
  • 努南谱系障碍患者合并非努南谱系障碍患者更常见房间隔缺损和/或肥厚型心肌病。
  • 瓣上型肺动脉狭窄与努南谱系障碍显著相关。
  • 与努南谱系障碍显著相关的心外特征包括喂养问题、生长发育迟缓、发育迟缓、身材矮小和眼部表现。
  • 努南谱系障碍诊断最强预测因素为隐睾(70%)、胸廓异常(66%)和眼部表现(48%),隐睾联合眼部表现时概率最高达92%。

关键数值与推荐

  • PVS患儿中努南谱系障碍患病率为9%。
  • 隐睾预测努南谱系障碍的概率为70%,胸廓异常为66%,眼部表现为48%。
  • 隐睾联合眼部表现预测努南谱系障碍的概率为92%。

临床怎么用

  • 接诊PVS患儿时应警惕努南谱系障碍,尤其合并房间隔缺损、肥厚型心肌病或瓣上型肺动脉狭窄时。
  • PVS患儿若伴喂养问题、生长发育迟缓、发育迟缓、身材矮小、眼部表现、隐睾或胸廓异常,应启动遗传学评估和RAS通路基因检测。
  • 瓣上型肺动脉狭窄患者应将努南谱系障碍纳入鉴别诊断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate the prevalence of Noonan spectrum disorders in a pediatric population with pulmonary valve stenosis (PVS) and explore other characteristics of Noonan spectrum disorders associated with PVS. STUDY DESIGN: A retrospective medical record review was completed for patients with a diagnosis of PVS seen at the Children's Hospital Colorado Cardiology clinic between 2009 and 2019. Syndromic diagnoses, genotypes, cardiac characteristics, and extracardiac characteristics associated with Noonan spectrum disorders were recorded; statistical analysis was conducted using R. RESULTS: Syndromic diagnoses were made in 16% of 686 pediatric patients with PVS, with Noonan spectrum disorders accounting for 9% of the total diagnoses. Individuals with Noonan spectrum disorders were significantly more likely to have an atrial septal defect and/or hypertrophic cardiomyopathy than the non-Noonan spectrum disorder individuals. Supravalvar pulmonary stenosis was also correlated significantly with Noonan spectrum disorders. Extracardiac clinical features presenting with PVS that were significantly associated with Noonan spectrum disorders included feeding issues, failure to thrive, developmental delay, short stature, and ocular findings. The strongest predictors of a Noonan spectrum disorder diagnosis were cryptorchidism (70%), pectus abnormalities (66%), and ocular findings (48%). The presence of a second characteristic further increased this likelihood, with the highest probability occurring with cryptorchidism combined with ocular findings (92%). CONCLUSIONS: The 9% prevalence of Noonan spectrum disorder in patients with PVS should alert clinicians to consider Noonan spectrum disorders when encountering a pediatric patient with PVS. The presence of PVS with 1 or more Noonan spectrum disorder-related features should prompt a genetic evaluation and genetic testing for RAS pathway defects. Noonan spectrum disorders should also be included in the differential when a patient presents with supravalvar pulmonary stenosis.

来源:J Pediatr,查看原文。版权归原作者所有。

引用

  1. Bell JM, Considine EM, McCallen LM, et al. The Prevalence of Noonan Spectrum Disorders in Pediatric Patients with Pulmonary Valve Stenosis. J Pediatr. 2021. PMID: 33794220. doi:10.1016/j.jpeds.2021.03.050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。